Phosphorylation of activation loop induces structural changes in c-Src tyrosine kinase leading to a conformational switch to the ATP binding conformation in the presence of the ligand
anti-leukemic drug imatinib (Gleevec). Upon phosphorylation, various conserved structural elements including the activation loop, switch from an inactive to an active form able to bind ATP and phosphorylate

